Stammdaten
GridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
Unternehmen & Branche
| Name | GridAI Technologies Corp. |
|---|---|
| Ticker | GRDX |
| CIK | 0001604191 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 7,6 Mio. USD |
| Beta | 1,10 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-09-30 | 10-Q | -1,152,809 | -0.75 | 135,370,340 | ||
| 2025-06-30 | 10-Q | -998,271 | -0.21 | 85,058,951 | -6,298,054 | |
| 2025-03-31 | 10-Q | -1,259,620 | -0.28 | 85,203,539 | -5,217,619 | |
| 2024-12-31 | 10-K | -18,059,336 | -5.33 | 85,409,506 | -3,876,738 | |
| 2024-09-30 | 10-Q | -2,580,971 | -1.76 | 85,820,620 | 8,369,003 | |
| 2024-06-30 | 10-Q | -8,807,702 | -3.86 | 86,287,453 | 9,120,595 | |
| 2024-03-31 | 10-Q | 5,567,606 | 0.38 | 91,133,902 | 16,182,844 | |
| 2023-12-31 | 10-K | -15,794,983 | -47.88 | 6,883,195 | 3,602,929 | |
| 2023-09-30 | 10-Q | -3,434,158 | -9.21 | 5,927,269 | 3,278,805 | |
| 2023-06-30 | 10-Q | -4,189,232 | -37.73 | 4,327,871 | 881,960 | |
| 2023-03-31 | 10-Q | -4,070,653 | -36.46 | 5,533,976 | 2,712,596 | |
| 2022-12-31 | 10-K | -14,629,642 | -416.94 | 5,439,699 | 2,742,152 | |
| 2022-09-30 | 10-Q | 4,391,331 | 18.23 | 4,645,403 | -2,280,049 | |
| 2022-06-30 | 10-Q | -5,408,145 | -53.47 | 3,927,274 | -14,189,863 | |
| 2022-03-31 | 10-Q | -9,626,839 | -138.28 | 8,825,439 | -9,239,785 | |
| 2021-12-31 | 10-K | -58,537,849 | -###.## | 11,789,976 | -7,821,550 | |
| 2021-09-30 | 10-Q | -30,400,788 | -98.00 | -6,969,988 | ||
| 2021-06-30 | 10-Q | -9,278,944 | -1.63 | 13,776,799 | 7,036,924 | |
| 2021-03-31 | 10-Q | -7,685,629 | -5.42 | 17,982,893 | 14,401,687 | |
| 2020-12-31 | 10-K | -32,671,466 | -14.68 | 12,923,855 | -2,640,693 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.